114 related articles for article (PubMed ID: 22750208)
1. Cortical thinning in amphetamine-type stimulant users.
Koester P; Tittgemeyer M; Wagner D; Becker B; Gouzoulis-Mayfrank E; Daumann J
Neuroscience; 2012 Sep; 221():182-92. PubMed ID: 22750208
[TBL] [Abstract][Full Text] [Related]
2. Medial prefrontal gray matter volume reductions in users of amphetamine-type stimulants revealed by combined tract-based spatial statistics and voxel-based morphometry.
Daumann J; Koester P; Becker B; Wagner D; Imperati D; Gouzoulis-Mayfrank E; Tittgemeyer M
Neuroimage; 2011 Jan; 54(2):794-801. PubMed ID: 20817105
[TBL] [Abstract][Full Text] [Related]
3. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
[TBL] [Abstract][Full Text] [Related]
4. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
Kish SJ; Lerch J; Furukawa Y; Tong J; McCluskey T; Wilkins D; Houle S; Meyer J; Mundo E; Wilson AA; Rusjan PM; Saint-Cyr JA; Guttman M; Collins DL; Shapiro C; Warsh JJ; Boileau I
Brain; 2010 Jun; 133(Pt 6):1779-97. PubMed ID: 20483717
[TBL] [Abstract][Full Text] [Related]
5. Learning and memory deficits in ecstasy users and their neural correlates during a face-learning task.
Roberts GM; Nestor L; Garavan H
Brain Res; 2009 Oct; 1292():71-81. PubMed ID: 19631624
[TBL] [Abstract][Full Text] [Related]
6. Developmental cortical thinning in fetal alcohol spectrum disorders.
Zhou D; Lebel C; Lepage C; Rasmussen C; Evans A; Wyper K; Pei J; Andrew G; Massey A; Massey D; Beaulieu C
Neuroimage; 2011 Sep; 58(1):16-25. PubMed ID: 21704711
[TBL] [Abstract][Full Text] [Related]
7. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
[TBL] [Abstract][Full Text] [Related]
8. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
Soar K; Turner JJ; Parrott AC
J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
[TBL] [Abstract][Full Text] [Related]
9. Focal thinning of the cerebral cortex in multiple sclerosis.
Sailer M; Fischl B; Salat D; Tempelmann C; Schönfeld MA; Busa E; Bodammer N; Heinze HJ; Dale A
Brain; 2003 Aug; 126(Pt 8):1734-44. PubMed ID: 12805100
[TBL] [Abstract][Full Text] [Related]
10. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
11. Frontal cortical thinning and subcortical volume reductions in early adulthood obesity.
Marqués-Iturria I; Pueyo R; Garolera M; Segura B; Junqué C; García-García I; José Sender-Palacios M; Vernet-Vernet M; Narberhaus A; Ariza M; Jurado MÁ
Psychiatry Res; 2013 Nov; 214(2):109-15. PubMed ID: 24041490
[TBL] [Abstract][Full Text] [Related]
12. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
13. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder.
Rimol LM; Hartberg CB; Nesvåg R; Fennema-Notestine C; Hagler DJ; Pung CJ; Jennings RG; Haukvik UK; Lange E; Nakstad PH; Melle I; Andreassen OA; Dale AM; Agartz I
Biol Psychiatry; 2010 Jul; 68(1):41-50. PubMed ID: 20609836
[TBL] [Abstract][Full Text] [Related]
14. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
Morgan MJ; McFie L; Fleetwood H; Robinson JA
Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
[TBL] [Abstract][Full Text] [Related]
15. Patterns of cortical thickness and surface area in early Parkinson's disease.
Jubault T; Gagnon JF; Karama S; Ptito A; Lafontaine AL; Evans AC; Monchi O
Neuroimage; 2011 Mar; 55(2):462-7. PubMed ID: 21184830
[TBL] [Abstract][Full Text] [Related]
16. Cortical thickness and VBM-DARTEL in late-life depression.
Colloby SJ; Firbank MJ; Vasudev A; Parry SW; Thomas AJ; O'Brien JT
J Affect Disord; 2011 Sep; 133(1-2):158-64. PubMed ID: 21550668
[TBL] [Abstract][Full Text] [Related]
17. Regional cerebral cortical thinning in bipolar disorder.
Lyoo IK; Sung YH; Dager SR; Friedman SD; Lee JY; Kim SJ; Kim N; Dunner DL; Renshaw PF
Bipolar Disord; 2006 Feb; 8(1):65-74. PubMed ID: 16411982
[TBL] [Abstract][Full Text] [Related]
18. Amphetamine dependence and co-morbid alcohol abuse: associations to brain cortical thickness.
Lawyer G; Bjerkan PS; Hammarberg A; Jayaram-Lindström N; Franck J; Agartz I
BMC Pharmacol; 2010 May; 10():5. PubMed ID: 20487539
[TBL] [Abstract][Full Text] [Related]
19. Smoking and structural brain deficits: a volumetric MR investigation.
Gallinat J; Meisenzahl E; Jacobsen LK; Kalus P; Bierbrauer J; Kienast T; Witthaus H; Leopold K; Seifert F; Schubert F; Staedtgen M
Eur J Neurosci; 2006 Sep; 24(6):1744-50. PubMed ID: 17004938
[TBL] [Abstract][Full Text] [Related]
20. Cocaine addiction as a neurological disorder: implications for treatment.
Majewska MD
NIDA Res Monogr; 1996; 163():1-26. PubMed ID: 8809851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
